Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Comparison of 99mTc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy.

Hunt KN, Conners AL, Goetz MP, O'Connor MK, Suman V, Kalari K, Weinshilboum R, Wang L, Carter J, McLaughlin S, Aspitia AM, Gray R, Northfelt D, Boughey JC.

AJR Am J Roentgenol. 2019 Jun 5:1-12. doi: 10.2214/AJR.18.20628. [Epub ahead of print]

PMID:
31166752
2.

99mTc-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.

Mitchell D, Hruska CB, Boughey JC, Wahner-Roedler DL, Jones KN, Tortorelli C, Conners AL, O'Connor MK.

Clin Nucl Med. 2013 Dec;38(12):949-56. doi: 10.1097/RLU.0000000000000248.

3.

The use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot study.

Wahner-Roedler DL, Boughey JC, Hruska CB, Chen B, Rhodes DJ, Tortorelli CL, Maxwell RW, Cha SS, O'Connor MK.

Clin Nucl Med. 2012 Apr;37(4):344-50. doi: 10.1097/RLU.0b013e31824437b3.

4.

Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.

Collarino A, de Koster EJ, Valdés Olmos RA, de Geus-Oei LF, Pereira Arias-Bouda LM.

Clin Breast Cancer. 2018 Feb;18(1):9-18. doi: 10.1016/j.clbc.2017.06.008. Epub 2017 Jun 29.

PMID:
28728876
5.

Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients.

Hruska CB, Weinmann AL, Tello Skjerseth CM, Wagenaar EM, Conners AL, Tortorelli CL, Maxwell RW, Rhodes DJ, O'Connor MK.

Med Phys. 2012 Jun;39(6):3476-83. doi: 10.1118/1.4719959.

6.

The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.

Nuvoli S, Galassi S, Gelo I, Rocchitta G, Fancellu A, Serra PA, Madeddu G, Spanu A.

Oncol Rep. 2018 May;39(5):2055-2062. doi: 10.3892/or.2018.6299. Epub 2018 Mar 6.

7.
8.

MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer.

Weber JJ, Jochelson MS, Eaton A, Zabor EC, Barrio AV, Gemignani ML, Pilewskie M, Van Zee KJ, Morrow M, El-Tamer M.

J Am Coll Surg. 2017 Dec;225(6):740-746. doi: 10.1016/j.jamcollsurg.2017.08.027. Epub 2017 Sep 15.

9.

Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.

Bouzón A, Acea B, Soler R, Iglesias Á, Santiago P, Mosquera J, Calvo L, Seoane-Pillado T, García A.

Radiol Oncol. 2016 Feb 16;50(1):73-9. doi: 10.1515/raon-2016-0007. eCollection 2016 Mar 1.

10.

Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.

O'Connor MK, Morrow MMB, Hunt KN, Boughey JC, Wahner-Roedler DL, Conners AL, Rhodes DJ, Hruska CB.

EJNMMI Res. 2017 Dec;7(1):5. doi: 10.1186/s13550-017-0255-6. Epub 2017 Jan 14.

11.

Assessment of Residual Disease With Molecular Breast Imaging in Patients Undergoing Neoadjuvant Therapy: Association With Molecular Subtypes.

Menes TS, Golan O, Vainer G, Lerman H, Schneebaum S, Klausner J, Even-Sapir E.

Clin Breast Cancer. 2016 Oct;16(5):389-395. doi: 10.1016/j.clbc.2016.05.015. Epub 2016 May 14.

PMID:
27282845
12.

Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer.

Ko ES, Han BK, Kim RB, Ko EY, Shin JH, Hahn SY, Nam SJ, Lee JE, Lee SK, Im YH, Park YH.

Ann Surg Oncol. 2013 Aug;20(8):2562-8. doi: 10.1245/s10434-013-2925-6. Epub 2013 Mar 6.

PMID:
23463090
13.

MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?

McGuire KP, Toro-Burguete J, Dang H, Young J, Soran A, Zuley M, Bhargava R, Bonaventura M, Johnson R, Ahrendt G.

Ann Surg Oncol. 2011 Oct;18(11):3149-54. doi: 10.1245/s10434-011-1912-z. Epub 2011 Sep 27.

PMID:
21947592
14.

Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.

Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA.

Mayo Clin Proc. 2005 Jan;80(1):24-30.

PMID:
15667025
15.

Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.

Sciuto R, Pasqualoni R, Bergomi S, Petrilli G, Vici P, Belli F, Botti C, Mottolese M, Maini CL.

J Nucl Med. 2002 Jun;43(6):745-51.

16.

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy.

Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY.

Cancer. 2008 Jan 1;112(1):17-26. Erratum in: Cancer. 2008 Apr 1;112(7):1642. Feig, Byon [corrected to Feig, Byron].

17.

Molecular Breast Imaging: Administered Activity Does Not Require Adjustment Based on Patient Size.

Tran TD, Ellingson LR, Swanson TN, Solberg CM, O'Connor MK, Hruska CB.

J Nucl Med Technol. 2018 Sep;46(3):265-267. doi: 10.2967/jnmt.117.203869. Epub 2018 Mar 29.

PMID:
29599399
18.

Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.

Lee SC, Grant E, Sheth P, Garcia AA, Desai B, Ji L, Groshen S, Hwang D, Yamashita M, Hovanessian-Larsen L.

J Ultrasound Med. 2017 May;36(5):901-911. doi: 10.7863/ultra.16.05060. Epub 2017 Feb 2.

PMID:
28150325
19.

MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.

Goorts B, Dreuning KMA, Houwers JB, Kooreman LFS, Boerma EG, Mann RM, Lobbes MBI, Smidt ML.

Breast Cancer Res. 2018 Apr 18;20(1):34. doi: 10.1186/s13058-018-0950-x.

20.

Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.

Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, Toledano AY, O'Connor MK.

AJR Am J Roentgenol. 2015 Feb;204(2):241-51. doi: 10.2214/AJR.14.13357.

Supplemental Content

Support Center